{"disease":{"id":"netherton-syndrome","name":"netherton syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03417856","title":"Defining the Skin and Blood Biomarkers of Ichthyosis","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT05388903","title":"A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT05856526","title":"A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT05521438","title":"Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Quoin Pharmaceuticals","has_results":false},{"nct_id":"NCT05583669","title":"A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT04244006","title":"A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":24,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT05789056","title":"Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Quoin Pharmaceuticals","has_results":false},{"nct_id":"NCT05902663","title":"Natural History of Netherton Syndrome","phase":"","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT06137157","title":"Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Azitra Inc.","has_results":false},{"nct_id":"NCT02113904","title":"Clinical Trial Using Humira in Netherton Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05979831","title":"A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT05211830","title":"A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Sixera Pharma","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}